Delivery Order SPE2DB20D3103-SPE2DB23FP7T8

Award Date 9/18/23
Potential Completion Date 9/19/23
Potential Value $8K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $12,128.68, was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of REXULTI 4 MG TABLET 30S, a pharmaceutical product. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC serves as a...
This federal contract award, valued at $2,112.67, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of REXULTI 1 MG TABLET 30S, a pharmaceutical product, to support military healthcare programs. The contract is a Delivery Order against an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which has a ceiling value of...
This federal contract award, valued at $9,608.51, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of REXULTI 1 MG TABLET 30S, a pharmaceutical product. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2026. This IDC serves as the...
This federal contract award, valued at $13,766.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of REXULTI 1 MG TABLET 30S, a pharmaceutical product. The contract has a ceiling value of $13,766.56 and an ultimate completion date of September 19, 2023. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $1,972.25, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of REXULTI 2 MG TABLET 30S, a pharmaceutical product. The award has an ultimate completion date of May 2, 2023 and is a Firm Fixed Price Delivery Order contract. The contract is not designated with any set-aside requirements, indicating it was awarded through full and open competition. Amerisourcebergen...
This federal contract award, valued at $5,621.59, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a wholly-owned subsidiary of Cencora, Inc. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The contract is for the delivery of REXULTI 2 MG TABLET 30S, a pharmaceutical product, to support military...
The U.S. government agency Defense Logistics Agency (DLA) Troop Support Medical awarded a Delivery Order contract worth $16,122.89 to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of REXULTI 1 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of October 30, 2023 and is a Firm Fixed Price type. This contract appears to be part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora,...
This federal contract award, valued at $20,117.98, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of the pharmaceutical product REXULTI 1 MG TABLET 30S. This award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December...
This federal contract award issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of REXULTI 2 MG TABLET 30S medical supplies. The fixed-price delivery order, valued at $6,807.19, has a completion date of November 8, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This...
This federal contract award, identified as SPE2DX15D2205|SPE2DX23F81HN, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of REXULTI 2 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $2,887.50 and a completion date of May 15, 2023. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB23FP7T8
    Delivery Order

This federal contract award, valued at $8,021.61, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of REXULTI 3 MG TABLET 30S, a pharmaceutical product, with a completion date of September 19, 2023.

The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 31, 2025. This IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs worldwide.

The contract award was made under full and open competition, with no set-aside designation. Amerisourcebergen Drug Corp, as a subsidiary of Cencora, Inc., has established itself as a critical supplier of essential medical commodities to various federal agencies, including the Department of Defense and Department of Justice.

Generated 5/12/25, 10:44 AM